XML 15 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Current assets:                    
Cash and cash equivalents ($7,202 and $4,414 related to VIEs) $ 99,082 [1] $ 160,491 $ 25,450 $ 11,974 $ 17,128 [1] $ 32,122 $ 11,333 $ 10,393 $ 15,076 [1] $ 9,850 [1]
Restricted cash 7,283 [1] 7,469 14,992 14,392 4,102 [1] 5,349 5,427 334    
Accounts receivable, net ($13,799 and $14,527 related to VIEs) 121,799 [1] 128,617 134,641 133,983 105,167 [1] 86,064 81,016 88,590    
Prepaid expenses ($651 and $628 related to VIEs) 8,728 [1] 8,516 7,319 8,995 7,577 [1] 7,898 7,383 7,549    
Inventories ($370 and $609 related to VIEs) 3,162 [1] 3,112 3,324 3,353 2,674 [1] 3,020 2,828 2,556    
Income taxes receivable ($0 and $0 related to VIEs) 4,432 [1] 3,944 3,739 3,003 2,425 [1] 1,299 1,003 484    
Deferred income taxes ($6 and $6 related to VIEs) 1,771 [1] 3,665 3,603 3,741 3,932 [1] 2,041 1,873 1,763    
Other ($403 and $47 related to VIEs) 8,291 [1] 8,635 8,024 12,773 11,731 [1] 10,313 6,681 7,911    
Total current assets 254,548 [1] 324,449 201,092 192,214 154,736 [1] 148,106 117,544 119,580    
Equity investments in joint ventures 1,646 [1] 1,596 2,925 2,769 2,555 [1] 684 781 666 575 692
Property and equipment, net ($19,051 and $17,786 related to VIEs) 269,570 [1] 273,330 274,054 273,991 239,237 [1] 216,369 223,341 216,602    
Real estate subject to finance obligation 22,552 [1] 17,743 16,476 15,175 19,239 [1] 20,704 20,465 19,350    
Goodwill ($54,377 and $23,970 related to VIEs) 476,559 [1] 449,277 493,708 682,667 579,875 [1] 506,145 507,017 488,186    
Intangible assets, net ($12,421 and $3,319 related to VIEs) 81,385 [1] 83,405 87,139 90,843 84,742 [1] 30,543 33,552 32,229    
Other assets ($6,335 and $6,035 related to VIEs) 47,184 [1] 48,142 50,413 51,940 49,969 [1] 47,539 50,108 51,091    
Total assets 1,153,444 [1] 1,197,942 1,125,807 1,309,599 1,130,353 [1] 970,090 952,808 927,704    
Current liabilities:                    
Accounts payable ($1,270 and $1,469 related to VIEs) 62,507 [1] 91,333 88,895 75,883 61,213 [1] 40,630 36,761 34,764    
Accrued expenses ($3,534 and $4,692 related to VIEs) 88,604 [1] 102,040 88,697 94,326 64,148 [1] 64,330 51,135 62,171    
Income taxes payable ($0 and $90 related to VIEs) 1,326 [1] 489 265 2,029 1,721 [1] 1,185 1,181 1,615    
Current portion of long-term debt ($14 and $13 related to VIEs) 26,350 [1] 25,950 38,180 31,172 17,536 [1] 12,333 12,907 10,502    
Current portion of finance obligation 433 [1] 361 278 255 317 [1] 298 283 279    
Other current liabilities 19,512 [1] 11,163 18,148 17,701 9,990 [1] 5,435 7,997 8,287    
Total current liabilities 198,732 [1] 231,336 234,463 221,366 154,925 [1] 124,211 110,264 117,618    
Long-term debt, less current portion ($11 and $25 related to VIEs) 940,771 [1] 942,963 1,097,473 1,087,479 974,130 [1] 837,810 799,028 749,792    
Finance obligation, less current portion 23,610 [1] 18,468 17,246 15,915 20,333 [1] 22,089 21,839 20,429    
Embedded derivative features of Series A convertible redeemable preferred stock 15,843 [1] 15,006                
Other long-term liabilities ($2,474 and $1,918 related to VIEs) 71,985 [1] 67,192 66,603 65,315 53,348 [1] 39,148 37,734 36,322    
Deferred income taxes 4,834 [1] 7,136 7,296 7,451 7,319 [1] 5,264 6,017 6,430    
Total liabilities 1,255,775 [1] 1,282,101 1,423,081 1,397,526 1,210,055 [1] 1,028,522 974,882 930,591    
Series A convertible redeemable preferred stock, $0.001 par value, $1,000 stated value, 3,500,000 and -0- authorized, 385,000 and -0- issued and outstanding at December 31, 2014 and 2013, respectively 319,997 [1] 304,271              
Noncontrolling interests - redeemable 15,273 [1] 15,685 16,000 15,973 15,899 [1] 15,933 16,350 11,379    
Commitments and contingencies [1] [1]    
Equity:                    
Common stock, $0.01 par value, 1,000,000 and 1,028 shares authorized, 1,028 issued and outstanding at December 31, 2014 and 2013, respectively [1]                
Additional paid-in capital 634,930 [1] 649,993 651,034 650,999 650,879 [1] 650,680 652,252 652,098    
Retained deficit (1,091,449) [1] (1,063,107) (975,224) (764,987) (734,158) [1] (716,383) (688,544) (667,710)   (487,656)
Accumulated other comprehensive loss, net of tax (36,920) [1] (36,411) (34,827) (34,119) (26,102) [1] (21,056) (17,269) (14,123)    
Total 21st Century Oncology Holdings, Inc. shareholder's deficit (493,439) [1] (449,525) (359,017) (148,107) (109,381) [1] (86,759) (53,561) (29,735)    
Noncontrolling interests - nonredeemable 55,838 [1] 45,410 45,743 44,207 13,780 [1] 12,394 15,137 15,469    
Total deficit (437,601) [1] (404,115) (313,274) (103,900) (95,601) [1] (74,365) (38,424) (14,266) 9,364 [1] 172,844 [1]
Total liabilities and equity 1,153,444 [1] $ 1,197,942 $ 1,125,807 $ 1,309,599 1,130,353 [1] $ 970,090 $ 952,808 $ 927,704    
Parent                    
Equity:                    
Accumulated other comprehensive loss, net of tax $ (36,920)       $ (26,102)       $ (11,823) $ (5,275)
[1] As Restated